#Intravenous Iron Drugs Market Market

[sanpdr1994]

Intravenous Iron Drugs Market Size Outlook Supply Applications Products Share Growth and Demand Budget Control Forecast 2032

Global Intravenous Iron Drugs Market was valued at US$ 2.6 Bn in 2021 and is expected to reach US$ 6.3 Bn by 2032, finds Fact.MR in a recent market survey. As per the findings of the report, Intravenous Iron Drugs revenue through Ferric Carboxymaltose will garner significant demand in the market as the bulk of revenue will be generated through them.

The American Heart Association predicts that by 2035, more than 130 million adults in the United States will have cardiovascular disease. In addition, the Centers for Disease Control and Prevention reports that 0.6 million Americans die each year from heart disease. This information leads directly to the number of hospital admissions.

The Ferric Carboxymaltose (FCM) segment led the market for intravenous iron medicines in 2021, with nearly 50% revenue share due to its expanding use, improved performance, and lower cost. It is a parenteral iron medication devoid of dextran which is suggested for the quick and high-dose replacement of depleted iron reserves. This medicine is a stable compound with the benefit of not containing any extraneous ingredients and having a very low immunogenic potential; hence, it poses a very low risk of anaphylactic responses. FCM has a higher effectiveness in terms of boosting hemoglobin levels and has fewer side effects. The tremendous rise may also be attributed to the FDA approval of Injectates in North America as well as its approval outside of North America.

The region's expanding senior population is a primary driver of industry development. According to US Census Bureau forecasts, the number of Americans aged 65 and older would rise from 52 million in 2018 to roughly 95 million by 2060. Furthermore, the overall percentage of people aged 65 and older is projected to increase from 16% to 23%.

It may be linked to the presence of a higher incidence of cancer, intestinal illnesses, and renal disease in the specific area. These conditions also are reinforcing its dominance. It has also contributed to the growth of women's health awareness and the awareness about celiac disease.

Competitive Landscape

Some of the key players in the global Intravenous Iron Drugs market include Vifor Pharma Management Ltd.; AMAG Pharmaceuticals; Daiichi Sankyo Company, Ltd.; Sanofi S.A.; Pharmacosmos A/S; Shield Therapeutics Plc; AbbVie Inc., Vifor Pharma Management Ltd.; AMAG Pharmaceuticals; Daiichi Sankyo Company, Ltd.; Sanofi S.A.; Pharmacosmos A/S; and Shield Therapeutics Plc among others.

Some of the recent developments in the Intravenous Iron Drugs Market are:

In April 2018, AMAG Pharmaceuticals got FDA clearance for a supplementary new drug application for ferumoxytol injection to cover all eligible people with iron-deficiency anaemia (IDA) who cannot tolerate or do not respond to oral iron.

In May 2019, Rockwell Medical, Inc. filed a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for the Intravenous (I.V.) version of Triferic.

In September 2020, Daiichi Sankyo announced the formation of its wholly-owned subsidiary Daiichi Sankyo Vietnam Company Limited. This program was launched in order to strengthen the company's Asian business platform.

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Intravenous Iron Drugs Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Product Type (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose, Other Product Types), by Indication (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, Other Applications), across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Market Segments Covered in Intravenous Iron Drugs Industry Analysis

By Product Type:

Iron Dextran

Iron Sucrose

Ferric Carboxymaltose

Other Product Types

By Indication:

Chronic Kidney Disease

Inflammatory Bowel Disease

Cancer

Other Applications

[creativeera]

The Iron Deficiency Anemia Treatment Market Is Thriving On Growing Demand

The iron deficiency anemia treatment market consists of oral iron replacement therapies that are used to treat low iron levels in the blood. Oral iron supplements offer convenience as they can be taken at home and have advantages like lower cost and fewer side effects compared to intravenous infusions. Iron deficiency anemia is a widespread nutritional disorder globally owing to insufficient dietary intake of iron or absorption issues. It can cause fatigue, weakness, and shortness of breath if left untreated. Global iron deficiency anemia treatment market is estimated to be valued at US$ 12.1 Bn in 2024 and is expected to reach US$ 21.6 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Key Takeaways Key players operating in the iron deficiency anemia treatment market are AdvaCare Pharma, Otsuka Pharmaceutical Co., Ltd., Sanofi, Emcure Pharmaceuticals, Wellona Pharma, SiNi Pharma Pvt Ltd, Sun Pharmaceutical Industries Ltd., Zydus Group, Akebia Therapeutics., Rockwell Medical, Inc., AbbVie Inc., Pfizer, Inc., Velnex Medicare, PHAEDRUS LIFE SCIENCE PVT. LTD., Inopha International Co, Limited, PharmaNutra S.p.A., Pharmascience Inc., American Regent, Inc. The growing Iron Deficiency Anemia Treatment Market Growth for oral iron replacement therapies owing to advantages like convenience of use and less side effects compared to intravenous infusions is fueling the market growth. Oral iron supplements can easily be taken at home without much supervision. The market is witnessing expansion in developing regions due to rising awareness and healthcare investments. There is a growing focus of market players on these regions through product launches, collaborations and mergers & acquisitions to strengthen their presence. Market Key Trends The market is witnessing high research and development activities by players to come up with innovative oral iron formulations. Iron Deficiency Anemia Treatment Market Size and Trends includes extended-release formulations with lower dosing frequency and tablets with enhanced biocompatibility for better iron absorption. Development of new pediatric formulations suitable for infants and children is also among the key research areas.

Porter���s Analysis Threat of new entrants: Low due to high costs involved to established production and distribution networks along with high capital requirements. Also, presence of few large players makes it difficult for new entrants. Bargaining power of buyers: Moderate as large number of generic alternatives available. However, severity and risk associated with condition increases buyer power. Bargaining power of suppliers: Moderate as raw material suppliers have limited control over pricing due to availability of substitutes. Threat of new substitutes: High due to emergence of alternative therapies and newer oral and injectable formulations. Competitive rivalry: Very high due to presence of many global and local players providing different treatment options. Intense competition keeps pricing pressure on existing products. Geographical Regions In terms of value, North America accounts for the largest share of the iron deficiency anemia treatment market due to growing prevalence of the disease and presence of advanced healthcare facilities. The U.S. is the major revenue generator within North America. Asia Pacific is the fastest growing region owing to rising geriatric population, increasing awareness regarding anemia, and improving access to healthcare services in emerging countries like India and China. The availability of low-cost generic drugs provides an impetus to market growth in Asia Pacific.

Get more insights on Iron Deficiency Anemia Treatment Market

Discover the Report for More Insights, Tailored to Your Language

French

German

Italian

Russian

Japanese

Chinese

Korean

Portuguese

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.

(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)

[severepeanutperfection]

Intravenous (IV) Iron Drugs Market Key Insights, Profiling Companies and Growth Strategies by 2032

The Intravenous (IV) Iron Drugs Market has experienced significant growth in recent years, driven by the rising prevalence of iron deficiency anemia and chronic kidney disease (CKD) worldwide. IV iron drugs are administered directly into the bloodstream to rapidly and effectively restore iron levels, making them a crucial treatment option for patients who cannot tolerate or do not respond well to oral iron supplementation. The market's expansion can be attributed to factors such as increasing awareness about iron deficiency-related conditions, advancements in drug formulations, and the growing aging population.

One of the key factors driving the Intravenous Iron Drugs Market is the increasing prevalence of iron deficiency anemia, particularly among women of childbearing age and individuals with gastrointestinal disorders. Iron deficiency anemia can have severe health consequences, leading to fatigue, weakness, and impaired cognitive function. IV iron drugs offer a fast and effective solution to replenish iron stores, providing a significant advantage over traditional oral iron supplements that may take longer to show results.

Additionally, the rising incidence of chronic kidney disease has contributed to the market's growth. Patients with CKD often experience anemia due to reduced erythropoietin production and impaired iron utilization. IV iron therapy has become an essential part of managing anemia in these patients, helping improve their quality of life and reducing the need for blood transfusions.

The Intravenous Iron Drugs Market has also benefited from advancements in drug formulations and delivery systems. Newer IV iron formulations have been developed to improve safety, efficacy, and patient convenience. These advancements have reduced the risk of adverse reactions and allowed for higher dosing, offering healthcare providers more flexibility in tailoring treatment regimens to individual patient needs.

Furthermore, the growing aging population has contributed to the market's expansion, as the elderly are more susceptible to iron deficiency anemia and CKD-related anemia. With a rising elderly population globally, the demand for IV iron drugs is expected to increase to address the healthcare needs of this demographic.

For More Info@ https://www.openpr.com/news/2709291/intravenous-iv-iron-drugs-market-size-share-global-industry

In conclusion, the Intravenous (IV) Iron Drugs Market has witnessed significant growth due to the increasing prevalence of iron deficiency anemia and chronic kidney disease. The rapid and effective iron replenishment provided by IV iron drugs, along with advancements in drug formulations and a growing aging population, are major driving factors. As awareness about iron deficiency-related conditions continues to rise and healthcare providers adopt advanced treatment options, the market for IV iron drugs is expected to further expand in the coming years.

[markettrend24]

Updated Reports on Intravenous Iron Drugs Market Size, Growth, Revenue, Regional Analysis 2022-2028

Updated Reports on Intravenous Iron Drugs Market Size, Growth, Revenue, Regional Analysis 2022-2028

Global Intravenous Iron Drugs Market Report 2022- Detailed Analysis of the Market Structure Along with Key Players, Size, Share, Various Segments, Factors Affecting the Market Growth and Forecast 2028 The latest report, Intravenous Iron Drugs Market Size 2022, by manufacturer, region, types, and application, forecast till 2028 is analysed and researched on the basis of comprehensive analysis of…

[neha24blog]

Intravenous Iron Drugs Market Size Is Poised To Reach USD 4.2 Billion By 2028: Grand View Research Inc.

Intravenous Iron Drugs Market Size Is Poised To Reach USD 4.2 Billion By 2028: Grand View Research Inc.

San Francisco, 13 Aug 2021: The Report Intravenous Iron Drugs Market Size, Share & Trends Analysis Report By Product (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose), By Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer), By Region, And Segment Forecasts, 2021 – 2028 The global intravenous iron drugs market size is expected to reach USD 4.2 billion by 2028, according to…

[ramshariraut]

Intravenous Iron Drugs  Market 2021-2028 | By Regions: Europe, North America, China and Japan.

Global Intravenous Iron Drugs  Market, Geography (North America (United States, Canada and Mexico), South America (China, Japan, Korea, India and Southeast Asia), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), Middle East and Africa (Saudi Arabia, Egypt, Nigeria and South Africa)) Industry Trends 2021-2028

<strong>Market Overview</strong> Illustrative analysis of critical sides such as resulting factors and competitive landscape are conveyed with the help of significant resources, such as charts, tables, graphs. The report executes a deep investigation of drivers and restraints operating in the market. The report also evaluates the trends observed in the parent market, along with the macro-economic indicators, prevailing factors, and market appeal according to different segments. The report also estimates the effect of different industrial sides on the Intravenous Iron Drugs   market divisions and regions. The research also divides the Intravenous Iron Drugs   Market on the basis of end-user, product type, application, and demography for the forecast period 2021–2028.

<strong> Request a sample Report of Intravenous Iron Drugs  Market @ <a href=https://www.statistifymarketresearch.com/reports/intravenous-iron-drugs-market/sample-request-84665>https://www.statistifymarketresearch.com/reports/intravenous-iron-drugs-market/sample-request-84665</a></strong>

<strong>Methodology</strong> The conditions influencing the market dynamics are considered and studied and examined to prepare an accurate report. In the report preparation process mainly two types of approaches are made- primary research approach and secondary research approach. In the primary research approach, both the supply and demand chain are interviewed where the supply chain consists of product, opinion leaders, etc. while the demand chain consists of industry experts. The secondary research approach involves various secondary sources like press releases, government agencies, and other commercial aspects of the market.

<strong>Report Summary</strong> Preparing a business report on Intravenous Iron Drugs    is the most important of all information-based writing because most of the business decisions are related to the organization after the evaluation of the situation as per the report. They are responsible for the documentation of the progress of the business and also serve several important purposes. The ability to write reports, quickly, and accurately is one of the key requirements of managers at every level. The reports allow them to convey vital information to subordinates and superiors. . The report on Intravenous Iron Drugs   prepared by us serves as a medium for understanding important business elements at the industrial and managerial level. Our report-making services entail flexible payment modes and budget-friendly rates.

<strong>Market segmentation</strong> The study splits the industry into a variety of sub-segments and thus represents the whole market. In addition, an estimate of the sales figures for the entire industry and its sub-segments are given in this report. It determines the variables that rapidly influence the market, including manufacturing methods and methodologies, channels for growth, and the product model. The report also outlines some of the biggest development opportunities, the introduction of the new products, market prediction, and forecasting, numerous economic factors that are key in deciding the Intravenous Iron Drugs  market pattern, buying decisions, and market attractiveness. The report would help stakeholders such as producers and distributors in finding and capturing high-potential markets. The research also addresses various environmental and regulatory critical factors.

<strong>Growth Mapping</strong> contains reason behind this report is to give a growth map with respect to the activities taken by key participants of the Intravenous Iron Drugs   market like item delivery, joint ventures,  influencing the Intravenous Iron Drugs   market and undertaking in general and furthermore influencing the business, import, fare, income and CAGR values. The report conveys the overall current realities about market definition, orders, applications, and commitment for the Intravenous Iron Drugs   market that are basic lead the market. The report moreover combines the overall organization profiles of the top players referred and also reflecting the drivers and limitations of the market with the support of SWOT analysis.

<strong>Top Listed Companies in the Intravenous Iron Drugs  Market Include</strong>

Allergan,Rockwell Medical,Galenica,AMAG Pharmaceuticals,NOXXON Pharma,Daiichi Sankyo,Wanbang Biopharmaceutical,Nippon Shinyaku,Pharmacosmos,Sanofi

<strong>Reasons to buy this report:</strong> Learn about the Covid-19 Impact on Intravenous Iron Drugs   market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements. To gain insightful analyses of the research Industry and have a comprehensive understanding of the global Intravenous Iron Drugs   market and its commercial landscape. To understand the future outlook and prospects for the Intravenous Iron Drugs   market with Marketing & Price (Price and Margin, Factors of Price Change, Manufacturers Gross Margin Analysis).

<strong>Request for Customization @ <a href=https://www.statistifymarketresearch.com/checkout/?currency=USD&type=single_user_license&report_id=84665>https://www.statistifymarketresearch.com/checkout/?currency=USD&type=single_user_license&report_id=84665</a></strong>

<strong>Regional Analysis</strong> Different regions of the world such as North America, Latin America, the Asia-Pacific region, Europe, and India, China, and Australia have been analyzed on the basis of various parameters that would benefit the development of the market in the area. It contains the territorial as well as the wide level investigation of the market. It was observed that North America and Asia-pacific countries have shown impressive development opportunities in their region. Asia-Pacific nations due to such a large population in the area could be the prime region for developing a fully flourishing market full of consumer and low-cost labor. However, Europe, being a region of most developed countries seems to be lagging in the survey due to its climatic-driven guidelines which will affect the new settlement of the market.

<strong>Customization of the report: </strong> The customized report is provided by our consultancy at a reasonable price. We provide updated information according to the requirements of the customers in the market world.

<strong>Benefits:</strong> 1. Well updated information. 2. Statistical report provided. 3. Discount offer in customization. 4. Service at the global level. 5. Company research report provided.

<strong>Services:</strong> 1. Expert analysts at your service. 2. Service according to your needs 3. Clearance of your queries. 4. Whole day service 5. Well updated Report.

<strong>Frequently Asked Questions?</strong> Q1. What is the total market value of the Intravenous Iron Drugs  market report? Q2. What would be the forecast period in the Intravenous Iron Drugs  market report? Q3. What is the base year considered in the Intravenous Iron Drugs   market report? Q4. Which are the top companies hold the market share in the Intravenous Iron Drugs   market ? Q5. Which is expected to be the fastest growing segment in the Intravenous Iron Drugs   market? Q6. Which market holds the maximum market share of the Intravenous Iron Drugs   market ? Q7. How the company profile has been selected? Q8. What will be the market value of the Intravenous Iron Drugs  market in 2028?

<strong>Why do companies trust Statistify Market Research?</strong> Statistify Market Research rendering surveys, indemnity, data, facts, enumeration on worldwide as well as local variables is one of the notable market research and expert company based in India. It covers automobiles, medicine, and healthcare, food and beverage, semiconductor and electronics market, chemicals, ICT(Information and Communications Technology), packaging, consumer goods. The flourishing company has a certain specified quality which provides customer satisfaction with excellent commitment and is highly time-oriented thus bringing positive results for our customers.

<strong>Company Name - Statistify Market Research</strong> Office Address - 156, Sector 9 Vasundhra Aptts Rohini, New Delhi 110085 IN Telephone Numbers - (+44) 162-237-1047 (+44) 162-237-1047 Email ID - <a href="mailto:sales@statistifymarketresearch.com"><strong>sales@statistifymarketresearch.com</strong></a> Contact Us – <a href="https://www.statistifymarketresearch.com/contact-us/"><strong>https://www.statistifymarketresearch.com/contact-us/</strong></a>

[crispyobjecttiger]

Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version) 2020-2026 which would mention How the Covid-19 is Affecting the Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Key Regions and Proposal for Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version) Players to battle Covid-19 Impact.

Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version) 2020-2026The

Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version) 2020-2026

report is one of the most comprehensive and important data about business strategies, qualitative and quantitative analysis of Global Market. It offers detailed research and analysis of key aspects of the Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version). The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version).

Top Leading players covered in the Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version) report : ​​​​​​​​​​​ Sanofi US Allergan AMAG Pharmaceuticals Dalichi Sankyo Luitpold Pharmaceuticals Pharmacosmos Takeda Pharmaceutical and More...

Get PDF Sample Report With Impact of COVID-19 on Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)@

https://www.mraccuracyreports.com/marketreports/7/406/Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

The report offers clear guidelines for players to cement a position of strength in the global Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version). It prepares them to face future challenges and take advantage of lucrative opportunities by providing a broad analysis of market conditions. the global Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version) will showcase a steady CAGR in the forecast year 2020 to 2026.

Market Segment by Type covers: Ferric Carboxymaltose Iron Sucrose Iron Dextran Others

Market Segment by Application covers: Nephrology Gynecology & Obstetrics Gastroenterology Oncology Cardiology Others

Our Complimentary Sample Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version) Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology.

Inquire and Get Up to 30% Discount By Clicking Here!  

https://www.mraccuracyreports.com/marketreports/7/406/Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Regions Covered in the Global Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version):

• The Middle East and Africa (GCC Countries and Egypt)

• North America (the United States, Mexico, and Canada)

• South America (Brazil etc.)

• Europe (Turkey, Germany, Russia UK, Italy, France, etc.)

• Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Years Considered to Estimate the Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version) Size:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2020-2026

Highlights of the Report:

• Accurate market size and CAGR forecasts for the period 2019-2026

• Identification and in-depth assessment of growth opportunities in key segments and regions

• Detailed company profiling of top players of the global Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

• Exhaustive research on innovation and other trends of the global Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

• Reliable industry value chain and supply chain analysis

• Comprehensive analysis of important growth drivers, restraints, challenges, and growth prospects

For Free Download Report:

https://www.mraccuracyreports.com/request/download/7/406/Intravenous (IV) Iron Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Reasons to buy:

Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying Top Manufacturer.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.

Report will be updated with the latest data and delivered to you within 2-4 working days of order.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis.

Create regional and country strategies on the basis of local data and analysis.

Customization of the Report: MR Accuracy Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Contact Us: Mr. Marcus Kel Call: +1 804 500 1224 / +44 741841 4156 (International) +91 7406728100 (ASIA) Email: sales@mraccuracyreports.com Website